Company profile for ReproNovo

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ReproNovo is redefining reproductive medicine and women’s health through innovative therapies for male and female infertility and uterine conditions like adenomyosis. Our international team combines expertise in reproductive medicine, drug development, regulatory strategy, and commercialization, with a proven track record of bringing therapies to market. Supported by leading investors including Jeito Capital, AXA IM Alts, M ...
ReproNovo is redefining reproductive medicine and women’s health through innovative therapies for male and female infertility and uterine conditions like adenomyosis. Our international team combines expertise in reproductive medicine, drug development, regulatory strategy, and commercialization, with a proven track record of bringing therapies to market. Supported by leading investors including Jeito Capital, AXA IM Alts, M Ventures, Ysios Capital, and ALSA Ventures, we operate from our headquarters in Lausanne, Switzerland, with key development teams in Copenhagen, Denmark, and Barcelona, Spain.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Rue de Langallerie 11 1003 Lausanne
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/07/01/3108003/0/en/ReproNovo-Announces-First-Participant-Included-in-U-S-Phase-2-Trial-of-RPN-001-for-Male-Infertility.html

GLOBENEWSWIRE
01 Jul 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/repronovo-raises-65-million-series-a-financing-to-advance-phase-2-cli-1030231

ACCESSWIRE
21 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty